• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Acute effects of pathogenic simian-human immunodeficiency virus challenge on vaccine-induced cellular and humoral immune responses to Gag in rhesus macaques.致病性猿猴-人类免疫缺陷病毒攻击对恒河猴疫苗诱导的针对Gag的细胞免疫和体液免疫反应的急性影响。
J Virol. 1999 Mar;73(3):1853-9. doi: 10.1128/JVI.73.3.1853-1859.1999.
2
Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.携带载体的Gag和Env而非Tat在Mamu - A*01阴性恒河猴中对猿猴 - 人类免疫缺陷病毒89.6P攻击显示出有效性。
J Virol. 2005 Oct;79(19):12321-31. doi: 10.1128/JVI.79.19.12321-12331.2005.
3
Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.通过具有复制能力的Ad5hr-SIVenv/rev和Ad5hr-SIVgag重组初免/gp120加强方案,增强恒河猴对直肠内猿猴免疫缺陷病毒SIV(mac251)攻击的保护作用。
J Virol. 2003 Aug;77(15):8354-65. doi: 10.1128/jvi.77.15.8354-8365.2003.
4
Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.AE亚型猿猴-人类免疫缺陷病毒初免和加强疫苗在猪尾猕猴中的比较疗效
J Virol. 2007 Jan;81(1):292-300. doi: 10.1128/JVI.01727-06. Epub 2006 Oct 18.
5
Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.静脉接种表达猿猴免疫缺陷病毒gag的复制缺陷型重组痘苗病毒DIs可控制猴体内的高致病性猿猴-人类免疫缺陷病毒。
J Virol. 2003 Dec;77(24):13248-56. doi: 10.1128/jvi.77.24.13248-13256.2003.
6
Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.用 DNA 疫苗接种恒河猴,随后用编码单纯免疫缺陷病毒(SIV)Gag 的腺病毒载体进行加强免疫,可延迟 SIV 经黏膜重复攻击引起的感染。
J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.00606-19. Print 2019 Nov 1.
7
Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease.表达HIV-1和SIV抗原的脊髓灰质炎病毒复制子在食蟹猴中的免疫原性及对SHIV-89.6P疾病的保护作用。
Virology. 2003 Oct 25;315(2):425-37. doi: 10.1016/s0042-6822(03)00546-4.
8
Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.接种疫苗的猕猴中猿猴免疫缺陷病毒感染的控制:与病毒特异性攻毒前后CD4+和CD8+ T细胞反应强度的相关性
J Immunol. 2002 Nov 1;169(9):4778-87. doi: 10.4049/jimmunol.169.9.4778.
9
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.用包裹在纳米颗粒中的Toll样受体配体辅助猿猴免疫缺陷病毒疫苗可诱导持续性抗体反应并增强对TRIM5α限制型猕猴的保护。
J Virol. 2017 Jan 31;91(4). doi: 10.1128/JVI.01844-16. Print 2017 Feb 15.
10
Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques.细胞毒性T淋巴细胞逃逸并不总能解释在腺病毒增强和DNA初免的Mamu-A*01阳性恒河猴中猴免疫缺陷病毒SIVmac239病毒血症的短暂控制。
J Virol. 2005 Dec;79(24):15556-66. doi: 10.1128/JVI.79.24.15556-15566.2005.

引用本文的文献

1
Polyphosphazene immunoadjuvants: Historical perspective and recent advances.聚膦嗪免疫佐剂:历史回顾与最新进展。
J Control Release. 2021 Jan 10;329:299-315. doi: 10.1016/j.jconrel.2020.12.001. Epub 2020 Dec 5.
2
Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.用重组 HLA Ⅰ类和Ⅱ类、HIV-1 gp140 和 SIV p27 免疫接种可在恒河猴中诱导针对异源 SHIV 感染的保护。
J Virol. 2011 Jul;85(13):6442-52. doi: 10.1128/JVI.00129-11. Epub 2011 Apr 13.
3
Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus.用抗FasL抗体治疗可在感染猿猴免疫缺陷病毒的猕猴中保留记忆淋巴细胞和病毒特异性细胞免疫。
Blood. 2009 Aug 6;114(6):1196-204. doi: 10.1182/blood-2009-02-202655. Epub 2009 Jun 4.
4
Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.用志贺氏菌DNA疫苗载体进行疫苗接种可诱导抗原特异性CD8(+) T细胞和抗病毒保护性免疫。
J Virol. 2001 Oct;75(20):9665-70. doi: 10.1128/JVI.75.20.9665-9670.2001.
5
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques.用破伤风类毒素疫苗接种可减轻受猿猴免疫缺陷病毒攻击的猕猴的疾病症状。
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3515-9. doi: 10.1073/pnas.97.7.3515.
6
Lymphocyte activation during acute simian/human immunodeficiency virus SHIV(89.6PD) infection in macaques.猕猴急性猿猴/人类免疫缺陷病毒SHIV(89.6PD)感染期间的淋巴细胞激活
J Virol. 1999 Dec;73(12):10236-44. doi: 10.1128/JVI.73.12.10236-10244.1999.

本文引用的文献

1
Recombinant, attenuated Salmonella typhimurium stimulate lymphoproliferative responses to SIV capsid antigen in rhesus macaques.重组减毒鼠伤寒沙门氏菌刺激恒河猴对猴免疫缺陷病毒衣壳抗原的淋巴细胞增殖反应。
Vaccine. 1999 Feb 26;17(7-8):923-32. doi: 10.1016/s0264-410x(98)00278-3.
2
Asymptomatic simian immunodeficiency virus infection decreases blood CD4(+) T cells by accumulating recirculating lymphocytes in the lymphoid tissues.无症状的猿猴免疫缺陷病毒感染通过在淋巴组织中积累再循环淋巴细胞来减少血液中的CD4(+) T细胞。
J Virol. 1999 Jan;73(1):601-7. doi: 10.1128/JVI.73.1.601-607.1999.
3
Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression.感染猿猴免疫缺陷病毒的恒河猴疾病的决定因素:对抗体反应低且进展迅速的动物进行特征描述。
J Gen Virol. 1998 Oct;79 ( Pt 10):2461-7. doi: 10.1099/0022-1317-79-10-2461.
4
Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS.经静脉、直肠或阴道接种后被致病性猿猴免疫缺陷病毒89.6-PD全身感染且未能迅速产生抗病毒抗体反应的恒河猴会迅速发展为艾滋病。
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):6-18. doi: 10.1097/00042560-199809010-00002.
5
CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques.CD4+ T细胞和CD20+ B细胞的变化可预测猕猴感染猴免疫缺陷病毒后疾病的快速进展。
J Virol. 1998 Feb;72(2):1600-5. doi: 10.1128/JVI.72.2.1600-1605.1998.
6
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.与病毒血症控制相关的强烈的HIV-1特异性CD4+ T细胞反应。
Science. 1997 Nov 21;278(5342):1447-50. doi: 10.1126/science.278.5342.1447.
7
Immunization of Macaca mulatta with aroA attenuated Salmonella typhimurium expressing the SIVp27 antigen.用表达猴免疫缺陷病毒p27抗原的aroA减毒鼠伤寒沙门氏菌对恒河猴进行免疫接种。
J Med Primatol. 1997 Feb-Apr;26(1-2):44-50. doi: 10.1111/j.1600-0684.1997.tb00318.x.
8
Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.1型人类免疫缺陷病毒Gag和Env蛋白抗体应答的差异调节
J Virol. 1997 Apr;71(4):2799-809. doi: 10.1128/JVI.71.4.2799-2809.1997.
9
Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinant S. typhimurium aroA mutant.
Vaccine. 1996 Feb;14(2):138-46. doi: 10.1016/0264-410x(95)00130-s.
10
A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.表达原发性患者1型人类免疫缺陷病毒分离株env的嵌合猿猴/人类免疫缺陷病毒在恒河猴体内传代后会引发类似艾滋病的疾病。
J Virol. 1996 Oct;70(10):6922-8. doi: 10.1128/JVI.70.10.6922-6928.1996.

致病性猿猴-人类免疫缺陷病毒攻击对恒河猴疫苗诱导的针对Gag的细胞免疫和体液免疫反应的急性影响。

Acute effects of pathogenic simian-human immunodeficiency virus challenge on vaccine-induced cellular and humoral immune responses to Gag in rhesus macaques.

作者信息

Steger K K, Waterman P M, Pauza C D

机构信息

Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, and Wisconsin Regional Primate Research Center, Madison, Wisconsin 53706, USA.

出版信息

J Virol. 1999 Mar;73(3):1853-9. doi: 10.1128/JVI.73.3.1853-1859.1999.

DOI:10.1128/JVI.73.3.1853-1859.1999
PMID:9971763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC104425/
Abstract

Simian-human immunodeficiency virus (SHIV) infection in macaques provides a convenient model for testing vaccine efficacy and for understanding viral pathogenesis in AIDS. We immunized macaques with recombinant, Salmonella typhimurium (expressing Gag) or soluble Gag in adjuvant to generate T-cell-dependent lymphoproliferative or serum antibody responses. Immunized animals were challenged by intrarectal inoculation with SHIV89.6PD. Virus infection was accompanied by rapid losses of lymphoproliferative responses to Gag or phytohemagglutinin. By 8 weeks, mitogen responses recovered to near normal levels but antigen-specific immunity remained at low or undetectable levels. Serum antibody levels were elevated initially by virus exposure but soon dropped well below levels achieved by immunization. Our studies show a rapid depletion of preexisting Gag-specific CD4(+) T cells that prevent or limit subsequent antiviral cellular and humoral immune responses during acute SHIV infection.

摘要

猕猴感染猿猴-人类免疫缺陷病毒(SHIV)为测试疫苗效力以及了解艾滋病病毒发病机制提供了一个便捷的模型。我们用重组鼠伤寒沙门氏菌(表达Gag)或佐剂中的可溶性Gag免疫猕猴,以产生T细胞依赖性淋巴细胞增殖或血清抗体反应。对免疫动物进行经直肠接种SHIV89.6PD攻击。病毒感染伴随着对Gag或植物血凝素的淋巴细胞增殖反应迅速丧失。到8周时,有丝分裂原反应恢复到接近正常水平,但抗原特异性免疫仍处于低水平或无法检测到的水平。血清抗体水平最初因接触病毒而升高,但很快降至远低于免疫所达到的水平。我们的研究表明,在急性SHIV感染期间,预先存在的Gag特异性CD4(+) T细胞迅速耗竭,从而阻止或限制了随后的抗病毒细胞免疫和体液免疫反应。